ARDT Ardent Health, Inc. - 8-K

Item 5.07.     Submission of Matters to a Vote of Security Holders.

Ardent Health, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 20, 2026. At the Annual Meeting, a total of 98,778,826 shares of the Company’s common stock, out of a total of 143,095,662 shares of common stock outstanding and entitled to vote as of the record date for the Annual Meeting, were represented in person or by proxy. Voting results from the Annual Meeting were as follows:

1. The following 11 director nominees were elected to the Company's Board of Directors, as follows:

For

Withhold

Broker Non-Votes

Mark Sotir

90,717,572

861,184

7,200,070

Martin J. Bonick

91,240,732

338,024

7,200,070

Peter Bulgarelli

91,267,887

310,869

7,200,070

Peter Bynoe

87,141,918

4,436,838

7,200,070

Suzanne Campion

91,271,694

307,062

7,200,070

Robert A. DeMichiei

91,243,922

334,834

7,200,070

William Goodyear

91,243,902

334,854

7,200,070

Ellen Havdala

86,273,698

5,305,058

7,200,070

Edmondo Robinson

91,328,193

250,563

7,200,070

Rahul Sen

79,335,440

12,243,316

7,200,070

Rob Webb

91,362,871

215,885

7,200,070

2.    The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows:

For

Against

Abstentions

Broker Non-Votes

91,093,535

300,746

184,475

7,200,070

3.    The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows:

For

Against

Abstentions

Broker Non-Votes

97,852,830

918,233

7,763

0